Huatge68

    • Huatge68Huatge68
      ·04-11
      21Comment
      Report
    • Huatge68Huatge68
      ·03-27
      $Tesla Motors(TSLA)$  Tesla going up and up again 
      511
      Report
    • Huatge68Huatge68
      ·03-26
      55Comment
      Report
    • Huatge68Huatge68
      ·2023-12-14
    • Huatge68Huatge68
      ·2023-10-31
      Let's join the fun oh yeahhhhh
      119Comment
      Report
    • Huatge68Huatge68
      ·2023-10-30

      Should be on top trading on PM

      $ABVC BioPharma, Inc.(ABVC)$  look out on Monday premarket 
      309Comment
      Report
      Should be on top trading on PM
    • Huatge68Huatge68
      ·2023-10-25
      Time to sell

      Wall Street Bets Broadcom May Extend Stock Election Deadline for VMware Holders in Merger

      While the two companies haven’t indicated any problems, the Financial Times reported last week that the Chinese State Administration of Market Regulation is likely to delay signing off on the deal and there will likely be additional consultations with Chinese government authorities. The FT cited people familiar with the matter.Investors are concerned that the Broadcom/VMware deal could fall victim to deteriorating U.S./China relations. The failure of China to OK Intel’s purchase of Tower Semicon
      Wall Street Bets Broadcom May Extend Stock Election Deadline for VMware Holders in Merger
      147Comment
      Report
    • Huatge68Huatge68
      ·2023-10-19
      Sell

      Netflix Wants More of Your Money, but Is the Streaming Industry Getting Too Cocky?

      Netflix implies its ad-supported tier is a fallback for consumers unhappy about price hikes -- but that only marks a return to an unwelcome past. Netflix Inc. once embodied the cutting edge of media, from its early days of sending DVDs by mail to its eventual transformation into a utopia of low-cost, high-quality, ad-free entertainment.Now the company appears to be taking a step backward. As it looks to bleed more money out of consumers with a new price hike announced Wednesday, the company promised that it would still offer affordability. Netflix's advertising-supported tier of service -- which launched almost a year ago -- will continue to cost $6.99 a month, a price the company calls "extremely competitive with other streamers" and better than the average cost of a movie ticket.Read: Netflix's stock jumps more than 10% on huge spike in subscribers, price hikes. Netflix said in its shareholder letter that its programming costs will be rising to about $17 billion next year, up from $
      Netflix Wants More of Your Money, but Is the Streaming Industry Getting Too Cocky?
      202Comment
      Report
    • Huatge68Huatge68
      ·2023-10-14
      Great ariticle, would you like to share it?

      CPI Inflation kills US market, like Birkenstock?

      @JC888
      On Wed, 11 Oct 2023 — US market continued its “green” march as investors: Follow up on US 10 years Treasury Yields Digest the Producer Price index (PPI) report. Poured over the central banks’ Sep 19-20, 2023 — minutes of meeting. Prepares to continue to assess the hotter-than-expected inflation data on Thu, 12 Oct 2023 when it is out. By the time market called it a day: DJIA: +0.19% (+65.57 to 33,804.81). S&P 500: +0.42% (+18.71 to 4,376.95). Nasdaq: +0.71% (+96.83 to 13,659.68). Best of the 3 indexes, still way off the 15,000 mark. Treasury yields continued to retreat (yesterday) from 16-year highs hit during the bond sell-off after Israel stepped up its bombardment of Gaza. On Wed, 11 Oct 2023, the benchmark 10-year yield traded below 4.6% (see above), compared with last week'
      CPI Inflation kills US market, like Birkenstock?
      213Comment
      Report
    • Huatge68Huatge68
      ·2023-10-14
      Great ariticle, would you like to share it?

      Healthcare Stocks Continue to Hit Records: LLY, AFL, MCK

      @WallStreet_Tiger
      1. $Eli Lilly(LLY)$ soared to a record high of $613 on October 12th.Eli Lilly and Novo Nordisk announced that it plans to stop a kidney outcomes clinical trial evaluating Ozempic (semaglutide) in treating patients with type 2 diabetes and chronic kidney disease.The study’s independent data monitoring committee recommended the trial be halted because results from an interim analysis showed an efficacy level that met pre-specified criteria.Lilly is also evaluating Mounjaro in a phase 2 study targeting chronic kidney disease. 2. $Aflac(AFL)$ climbed to $80.50 on October 12th.Aflac is a supplemental health and life insurance provider in the US and Japan. The company has been expanding its product offe
      Healthcare Stocks Continue to Hit Records: LLY, AFL, MCK
      162Comment
      Report
       
       
       
       

      Most Discussed

       
       
       
       
       

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email:uservice@ttm.financial